While microdosing tirzepatide protocols are well-established, microdosing semaglutide during transitions is less standardized but gaining interest
doi: 10.3389/fendo.2024.1484838 Received 22 August 2024 Accepted 29 October 2024 Published 14 November 2024 Volume 15 - 2024 Edited by Chao Cheng, Wuxi Peoples Hospital of Nanjing Medical University, China Reviewed by Aimin Jiang, Fudan University, China Jiaheng Xie, Central South University, China Updates Copyright 2024 Hu, Tian, Deng, Wang, Li, Wang, Liu and Li
This improvement occurs because fulvic acid helps prevent the formation of insoluble iron complexes that often occur in the digestive tract, making the mineral more available for absorption
Annu Rev Med 66:311328
Doses up to 600 mg were generally well-tolerated with no clinically significant abnormalities in blood pressure or heart rate, no observed skin pigmentation, and no significant changes to adrenal, urinary or hematology panels